Factors such as altered drug absorption and decreased clearance due to impaired renal or hepatic activity can significantly affect how drugs will behave with use.
As many as 300,000 Canadians could have CD; however, many remain undiagnosed. The disease can be difficult to diagnose since it can present with a variety of symptoms at any point in life.
It is imperative that pharmacy is engaging with these companies to ensure that they are aware of the range of services that pharmacists can perform for patients.